A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient.

Harbi, Shmeylan Al; AlFaifi, Mashael; Al-Dorzi, Hasan M; Aljuhani, Ohoud; Alenazi, Abeer A; Alalawi, Mai; Sulaiman, Khalid Al

Harbi, Shmeylan Al; AlFaifi, Mashael; Al-Dorzi, Hasan M; Aljuhani, Ohoud; Alenazi, Abeer A; Alalawi, Mai; Sulaiman, Khalid Al.

Afiliação

Harbi SA; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
AlFaifi M; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Al-Dorzi HM; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Aljuhani O; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Alenazi AA; Pharmaceutical Services Administration, King Saud Medical City, Riyadh. Saudi Arabia.
Alalawi M; King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Sulaiman KA; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

IDCases ; 29: e01572, 2022.

Article em En | MEDLINE | ID: mdl-35855472

Palavras-chave

Coronavirus disease 2019 (Covid-19); QTc prolongation; Remdesivir

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: IDCases Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google